Department of Health
and Human Services (HHS)
and Human Services (HHS)
September 14, 2021
PAR-22-029 - Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to extend the due date for PAR-22-029 "Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)". The new application due date is October 22, 2021. See below for changes to the Funding Opportunity Announcement (FOA).
Currently Reads:
Part 1. Overview Information
Key Dates:
Open Date: September 5, 2021
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 05, 2021 * | Not Applicable | Not Applicable | March 2022 | May 2022 | July 2022 |
Expiration Date October 6, 2021
Modified to Read:
Part 1. Overview Information
Key Dates:
Open Date: September 22, 2021
| Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 22, 2021 * | Not Applicable | Not Applicable | March 2022 | May 2022 | July 2022 |
Expiration Date October 23, 2021
All other aspects of this FOA remain unchanged.
Daniel Miller, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: daniel.miller@nih.gov